<DOC>
	<DOCNO>NCT02682524</DOCNO>
	<brief_summary>A multicenter , randomize , double-blinded , parallel , active-controlled , phase IV clinical trial evaluate efficacy safety PlbCR aceclofenac treatment patient osteoarthritis knee</brief_summary>
	<brief_title>Phase IV Clinical Trial Evaluate Efficacy Safety PlbCR Aceclofenac Treatment Patients With Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Aceclofenac</mesh_term>
	<criteria>male female 35yearold 80yearold patient diagnose Kellgren &amp; Lawrence stage I~III Xray osteoarthritis patient stable within 3months form start clinical trial patient 40mm 100mm Pain VAS Visit 2 patient agree participate clinical trial spontaneously second osteoarthritis patient inflammatory disease effect efficacy outcomes bursitis , tenosynovitis , rheumatoid arthritis , etc . patient diagnose gastric ulcer GI disease esophagogastroduodenoscopy patient joint surgery within 12months form screen visit clinical trial plan operate clinical trial period patient artificial joint surgery knee malignant tumor patient patient take Psychopharmaceutical Narcotic Analgesics 3months continuously patient take steroid oral , inhalation intraarticular injection within 3months form screen visit clinical trial patient take intraarticular hyaluronic acid injection knee within 2months form screen visit clinical trial patient take NSAIDs disease medicine allergy aspirin NSAIDs patient handle his/her pain CABG galactose intolerance , Lactose Intolerance glucosegalactose malabsorption inflammatory bowel disease ulcerative colitis Crohn 's disease moderate renal disease moderate hepatic disease moderate hypertension ( SBP= &gt; 160mmHg , DBP= &gt; 100mmHg ) female consent contracept patient appropriate clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>